NEUROMODULATION DEVICE






A well-funded implantable technology development company focusing on solutions for hypertension and heart failure needed development of a proof of concept for a delivery tool for deployment of active implantable lead.
Software development was needed for device control communication and device usage tracking for lifetime estimates.